Lataa...
Bcl-2 turns deadly
Small-molecule inhibitors of anti-apoptotic Bcl-2 proteins and BH3 mimetic peptides are promising anticancer agents. A recent study identifies a Nur77-based peptide that converts anti-apoptotic Bcl-2 proteins into proapoptotic molecules, providing another potential cancer therapeutic strategy.
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2008
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2630477/ https://ncbi.nlm.nih.gov/pubmed/19008882 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nchembio1208-722 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|